The Results Are In from Quest Diagnostics®
The Results Are In from Quest Diagnostics®
Podcast Description
Physicians routinely diagnose and treat acute and chronic conditions
across multiple clinical areas. Whether it’s a condition studied for
decades or an emerging infection, comprehensive diagnostic testing is
enabling faster and more effective care to drive better patient outcomes.
In fact, most medical decisions are based at least partly on lab testing!
On The Results Are In from Quest Diagnostics®, we are joined by
diagnostics industry leaders who support providers in optimizing care
pathways for their patients. From the latest in cutting-edge research to
the real-world impact of diagnostic testing on treatment journeys, The
Results Are In features can’t-miss stories for those wanting to stay in the
know about the latest innovations in laboratory diagnostics.
Podcast Insights
Content Themes
The podcast focuses on a variety of topics within the field of diagnostics, such as innovative lab testing techniques, the role of biomarkers in early detection of diseases like Alzheimer’s, and the impact of diagnostic choices on patient care. Episodes highlight case studies, like the integration of blood-based biomarkers for Alzheimer’s risk assessment, underscoring trends that shape healthcare delivery.
Physicians routinely diagnose and treat acute and chronic conditions
across multiple clinical areas. Whether it’s a condition studied for
decades or an emerging infection, comprehensive diagnostic testing is
enabling faster and more effective care to drive better patient outcomes.
In fact, most medical decisions are based at least partly on lab testing!
On The Results Are In from Quest Diagnostics®, we are joined by
diagnostics industry leaders who support providers in optimizing care
pathways for their patients. From the latest in cutting-edge research to
the real-world impact of diagnostic testing on treatment journeys, The
Results Are In features can’t-miss stories for those wanting to stay in the
know about the latest innovations in laboratory diagnostics.
Tick-borne diseases are becoming an increasing concern across the United States, with rising case counts and expanding geographic spread. While Lyme disease remains the most recognized infection, clinicians are now facing a broader range of pathogens and more complex cases involving co-infections.
In this episode of The Results Are In from Quest Diagnostics, host Anne Freeman sits down with Dr. Ann Salm, PhD, Director and Medical Science Liaison Lead for Infectious Disease and Immunology at Quest. Together, they walk through the growing burden of tick-borne illness, the environmental and ecological factors driving its rise, and why accurate diagnosis is becoming more challenging.
They break down the importance of timing when selecting diagnostic tests, explaining when molecular testing versus serologic testing is most effective. The conversation also explores the evolution of Lyme disease testing, from standard two-tier testing to the modified two-tier approach, and how newer methods can improve early detection.
Listeners will also gain insight into co-infections like anaplasmosis, ehrlichiosis, and babesiosis, and how comprehensive testing panels can support better clinical decision-making. The episode highlights how providers can approach testing strategically to improve patient outcomes in an increasingly complex diagnostic landscape.
Don’t miss this practical and timely discussion on how testing advancements are shaping the future of tick-borne disease management.
Follow Us
Twitter @QuestDX
Facebook @QuestDiagnostics
Instagram @QuestDiagnostics
LinkedIn @QuestDiagnostics
Abbreviations used in episode:
CDC: Centers for Disease Control and Prevention
IgG: Immunoglobulin G
IgM: Immunoglobulin M
STTT: Standard Two-Tier Testing
MTTT: Modified Two-Tier Testing
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.